Our researchers have numerous academic collaborations. Maas researchers
are willing to test new cyclosporin analogs from academia or industry.
Maas Biolab recently entered into a Cooperative Research and Development Agreement (CRADA) with the Walter Reed Army Institute of Research Division of Military Casualty Research. The two parties are investigating the neuroprotective properties of cyclosporin in models of battlefield traumatic brain injury and nerve agent attack.
See the Walter Reed Army Institute of Research/Maas Biolab joint press release.
The Maas Biolab Clinical and Scientific Advisory Board (C&SAB) is composed of internationally recognized cyclosporin experts.
Maas Clinical and Scientific Advisory Board Profiles
Maas Biolab researchers and scientific advisors are at the:
- Chicago Institute of Neurosurgery and Neuroresearch (CINN)
- Medical College of Georgia
- Oregon Health Sciences Center
- University of Kentucky
- University of Lund, Sweden
- University of New Mexico
- University of South Florida
Eskil Elmér, M.D., Ph.D.
Chief Scientific Officer:
Maas Biolab has collaborations to develop new cyclosporin analogs
with radically improved pharmacologic characteristics.
We are open to licensing our intellectual property, and establishing
Director of Operations: